Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.02
+0.92 (5.08%)
Mar 6, 2026, 4:08 PM HKT
Market Cap2.59B
Revenue (ttm)2.34M -13.4%
Net Income-123.26M
EPS-11.28
Shares Out136.22M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume451,500
Average Volume121,554
Open18.00
Previous Close18.10
Day's Range18.00 - 19.48
52-Week Range13.48 - 32.00
Beta0.84
RSI53.40
Earnings Daten/a

About HKG:3378

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. develops and manufactures immunotherapies for cancer and autoimmune diseases. The company's products include antibody drugs, including monoclonal, bispecific, and antibody drug conjugates for immuno-oncology pathways. The company was incorporated in 2014 and is headquartered in Wuhan, China. [Read more]

Founded 2014
Employees 55
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3378
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements